MeSH D011537 - pruritus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Doxepin | Doxepin |  | 1987-11-09 |  |  |
| Hydroxyzine | Hy-pam |  | 1985-03-04 |  |  | |
| Hydroxyzine | Hydroxyzine |  | 1982-01-01 |  |  | |
| Hydroxyzine | Hydroxyzine Pamoate |  | 1982-03-05 |  |  | |
| Padagis | Mometasone furoate | Mometasone Furoate |  | 2002-03-18 |  |  |
| Taro Pharmaceutical | Doxepin | Doxepin |  | 2020-07-01 |  |  |
| Mometasone furoate | Mometasone Furoate |  | 2004-12-03 |  |  | |
| Glenmark Pharmaceuticals | Mometasone furoate | Mometasone Furoate |  | 2008-05-28 |  |  |
| Olopatadine, Mometasone furoate | Ryaltris | 2034-09-04 | 2022-01-13 |  |  | |
| Mylan | Doxepin | Doxepin |  | 1986-05-13 |  |  |
| Hydrocortisone, Pramoxine | Epifoam |  | 1982-01-01 |  |  | |
| Hydrocortisone, Pramoxine | Proctofoam |  | 1982-01-01 |  |  | |
| Doxepin | Zonalon |  | 1994-04-01 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
61%11/18
Phase 2
41%17/41
Phase 3
75%30/40
Approved: 21Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use